dacarbazine and Prostatic Neoplasms, Castration-Resistant

dacarbazine has been researched along with Prostatic Neoplasms, Castration-Resistant in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Alumkal, JJ; Carducci, MA; Cetnar, J; Chyla, B; Giranda, VL; Hussain, M; McKeegan, EM; Qian, J; Refici-Buhr, M; Shepherd, SP; Slovin, S	1

Trials

1 trial(s) available for dacarbazine and Prostatic Neoplasms, Castration-Resistant

Article	Year
Targeting DNA repair with combination veliparib (ABT-888) and temozolomide in patients with metastatic castration-resistant prostate cancer. Investigational new drugs, 2014, Volume: 32, Issue:5 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Dacarbazine; DNA Repair; Humans; Kallikreins; Male; Middle Aged; Pilot Projects; Poly(ADP-ribose) Polymerase Inhibitors; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Temozolomide; Treatment Outcome	2014

Article

Year

Targeting DNA repair with combination veliparib (ABT-888) and temozolomide in patients with metastatic castration-resistant prostate cancer.

Investigational new drugs, 2014, Volume: 32, Issue:5

Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Dacarbazine; DNA Repair; Humans; Kallikreins; Male; Middle Aged; Pilot Projects; Poly(ADP-ribose) Polymerase Inhibitors; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Temozolomide; Treatment Outcome

2014